Glycemic Control For Diabetes Mellitus

4

Review clinical trials related to Glycemic Control For Diabetes Mellitus. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Video-Based Lifestyle Counseling in Adults With Type 2 Diabetes.

This study evaluates the effectiveness of a 3-month video-based lifestyle intervention, focused on promoting healthy lifestyle habits (healthy eating and increased physical activity), on adults with type 2 diabetes mellitus (DM2). Participants will be randomly allocated to receive the intervention either delivered by their own physician (experimental group) or by a physician unknown to them (control group). Assessment will include sociodemographic variables, glycated hemoglobin / HbA1c (primary outcome), body mass index, blood pressure, glycemic and lipid metabolism variables, physical activity level, adherence to the Mediterranean diet, therapeutic alliance, and health-related quality of life. The randomization process will be stratified according to HbA1c, therapeutic alliance, age, and sex.

Participants needed: 156
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Cardenal Herrera UniversityUpdated: Apr 29, 2026Locations: 1
Eligibility criteria

Adults aged 18-65 years [+4]

Pregnancy [+8]

Status: Recruiting

Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes

The purpose of this study is to see if the study drug CIR-0602K will improve glucose time-in-range and/or lower total daily insulin dose in people with type 1 diabetes who are using closed-loop automated insulin delivery. Researchers will compare CIR-0602K to a placebo (a look-alike substance that contains no drug) to see if it achieves the investigational endpoints. If the study results show that the drug works to increase time-in-range and lower insulin doses, this will lead to further studies which may then make the drug available to the public.

Participants needed: 40
Trial details
Phase: Phase 2Age: 18-45Biological sex: AllType: InterventionalSponsor: University of VirginiaUpdated: Feb 25, 2026Locations: 1
Eligibility criteria

Provision of signed and dated informed consent form [+12]

Current Pregnancy or currently breastfeeding. [+18]

Status: Not yet recruiting

Semaglutide Treatment in Type 1 Diabetes

The goal of this clinical trial is to investigate the efficacy of semaglutide on body weight, insulin dose requirements and improvements in glucose control and safety aspects in regards to risk of hypoglycemia and diabetic ketoacidosis for patients with established Type 1 Diabetes.

Participants needed: 122
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Nordsjaellands HospitalUpdated: Aug 8, 2025Locations: 1
Eligibility criteria

Type 1 Diabetes for more than 3 years [+1]

Treated with GLP1-RAs within last 6 months [+11]

Status: Not yet recruiting

Meal Frequency and Glycemic Control in Individuals With Type 1 Diabetes

The goal of this clinical trial is to examine the effect of 3 versus 6 daily meals of isocaloric diets on glycemic control and variability in individuals with type 1 diabetes. Participants will be randomized in a crossover clinical trial and will receive two different types of isocaloric diet interventions, in 3 meals/day (calorie distribution: 30% at breakfast, 40% at lunch and 30% at dinner) or 6 meals/day (calorie distribution: 20% at breakfast, 10% at morning snack, 30% at lunch, 10% at afternoon snack, 25% at dinner and 5% at evening snack), for three weeks, with a 4-week washout period between diets.

Participants needed: 27
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Hospital de Clinicas de Porto AlegreUpdated: Apr 18, 2025Locations: 1
Eligibility criteria

• Adults (18 to 60 years old) with a medical diagnosis of type 1 diabetes mellit... [+6]

Individuals with glycated hemoglobin ≥ 11% [+17]